Research Frontiers Inc. Files 2023 Annual Report on Form 10-K

TL;DR

<b>Research Frontiers Inc. filed its 2023 10-K report on March 7, 2024, detailing its fiscal year-end results.</b>

AI Summary

RESEARCH FRONTIERS INC (REFR) filed a Annual Report (10-K) with the SEC on March 7, 2024. Research Frontiers Inc. reported its 2023 fiscal year results on March 7, 2024. The company's fiscal year ends on December 31st. The filing is a 10-K annual report. Research Frontiers Inc. is incorporated in Delaware. The company's principal business address is in Woodbury, NY.

Why It Matters

For investors and stakeholders tracking RESEARCH FRONTIERS INC, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Research Frontiers Inc.'s financial performance and business operations for the fiscal year ended December 31, 2023. Investors and analysts can use this report to assess the company's financial health, strategic direction, and potential risks.

Risk Assessment

Risk Level: low — RESEARCH FRONTIERS INC shows low risk based on this filing. The filing is a standard 10-K, indicating routine disclosure rather than immediate significant events.

Analyst Insight

Review the detailed financial statements and risk factors within the 10-K to understand Research Frontiers Inc.'s performance and outlook.

Key Numbers

• 2023-12-31 — Fiscal Year End (CONFORMED PERIOD OF REPORT)
• 2024-03-07 — Filing Date (FILED AS OF DATE)
• 000-14893 — SEC File Number (SEC FILE NUMBER)
• 24729955 — Film Number (FILM NUMBER)

Key Players & Entities

• Research Frontiers Inc. (company) — FILER
• 2023 (date) — CONFORMED PERIOD OF REPORT
• 2024-03-07 (date) — FILED AS OF DATE
• Woodbury (location) — CITY
• NY (location) — STATE
• 11797-2033 (postal_code) — ZIP
• 5163641902 (phone_number) — BUSINESS PHONE
• DE (location) — STATE OF INCORPORATION

FAQ

Industry Context

Research Frontiers Inc. operates in the patent owners and lessors industry, focusing on licensing its technology.

Regulatory Implications

The company is subject to standard SEC reporting requirements for publicly traded companies, including the filing of annual 10-K reports.

What Investors Should Do

1. Analyze the financial statements for revenue trends and profitability.
2. Examine the business description for any changes in operations or strategy.
3. Review the risk factors section for potential challenges and uncertainties.

Key Dates

• 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K.
• 2024-03-07: Filing Date — Date Research Frontiers Inc. submitted its 10-K to the SEC.

Year-Over-Year Comparison

This is the 2023 10-K filing, providing the latest annual financial and operational data for Research Frontiers Inc.

Key Financial Figures

• $0.0001 — s on Which Registered Common Stock, $0.0001 Par Value The NASDAQ Stock Market
• $1.60 — uted based on the closing sale price of $1.60 was $ 51,773,808 . In making this compu
• $2.8 billion — ass market is expected to grow from USD $2.8 billion in 2016 to reach USD $8.35 billion by 2
• $8.35 billion — m USD $2.8 billion in 2016 to reach USD $8.35 billion by 2023, with a growth rate of 16.6% be
• $5.0 billion — ass market is expected to grow from USD $5.0 billion in 2022 to reach USD $8.2 billion by 20
• $8.2 billion — m USD $5.0 billion in 2022 to reach USD $8.2 billion by 2027, with a growth rate of 10.4% be
• $5.8 billion — market is expected to be valued at USD $5.8 billion in 2024 and is projected to reach USD $
• $9.4 billion — n in 2024 and is projected to reach USD $9.4 billion by 2029. It is expected to grow at a CA
• $3.7 billion — ass market is expected to grow from USD $3.7 billion in 2018 to reach USD $8.6 billion by 20
• $8.6 billion — m USD $3.7 billion in 2018 to reach USD $8.6 billion by 2025 reflecting a growth rate of 15.

Filing Documents

• form10-k.htm (10-K) — 1190KB
• ex21.htm (EX-21) — 4KB
• ex23-1.htm (EX-23.1) — 3KB
• ex31-1.htm (EX-31.1) — 11KB
• ex32-1.htm (EX-32.1) — 8KB
• 0001493152-24-009207.txt (&nbsp;) — 4161KB
• refr-20231231.xsd (EX-101.SCH) — 32KB
• refr-20231231_cal.xml (EX-101.CAL) — 44KB
• refr-20231231_def.xml (EX-101.DEF) — 98KB
• refr-20231231_lab.xml (EX-101.LAB) — 269KB
• refr-20231231_pre.xml (EX-101.PRE) — 195KB
• form10-k_htm.xml (XML) — 448KB

BUSINESS

BUSINESS Forward-Looking Information included in this Annual Report on Form 10-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Annual Report on Form 10-K under "Item 1A. – Risk Factors" below. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Annual Report on Form 10-K. General: As used herein, "we," "us," "our," the "Company" or "Research Frontiers" means Research Frontiers Incorporated unless otherwise indicated. Research Frontiers operates in a single business segment which is engaged in the development and marketing of technology and devices to control the flow of light (see Note 1 to the Consolidated Financial Statements). We develop and license our patented suspended particle device ("SPD-Smart") light-control technology to other companies that manufacture and/or market t

View Full Filing

View this 10-K filing on SEC EDGAR